Range
- - -
Vol / Avg.
-/3M
Div / Yield
-
52 Wk
2.77 - 7.75
Mkt Cap
244.4M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.49
Shares
57.9M
Outstanding
57.9M
Total Float
51.8M
load more
Sector: Health Care.Industry: Pharmaceuticals
Chiasma Inc is a commercial-stage biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for rare and serious chronic disease. The US Food and Drug Administration, or the FDA, approved MYCAPSSA for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. MYCAPSSA is the first and only oral somatostatin analog, or SSA, approved by the FDA and the first product approved by the FDA utilizing TPE technology. The company is focused on the commercialization of MYCAPSSA for the treatment of patients with acromegaly in the United States and developing and seeking regulatory approval of MYCAPSSA in the European Union.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.310-0.490 -0.1800
REV1.820M1.587M-233.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CHMAChiasma0%244.4M

Chiasma Frequently Asked Questions

Q

How do I buy Chiasma (CHMA) stock?

A

You can purchase shares of Chiasma (NASDAQ: CHMA) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Chiasma (CHMA) stock?

A

The latest price target for Chiasma (NASDAQ: CHMA) was reported by Jefferies on August 13, 2020. The analyst firm set a price target for 8.00 expecting CHMA to rise to within 12 months (a possible 89.57% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Chiasma (CHMA)?

A

The stock price for Chiasma (NASDAQ: CHMA) is $4.22 last updated Wed Jun 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Chiasma (CHMA) pay a dividend?

A

There are no upcoming dividends for Chiasma. The last dividend paid out to investors was $0.65 on March 16, 2018.

Q

When is Chiasma (NASDAQ:CHMA) reporting earnings?

A
Chiasma’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Chiasma (CHMA) going to split?

A

There is no upcoming split for Chiasma.

Q

What sector and industry does Chiasma (CHMA) operate in?

A

Chiasma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.